A non-invasive, point-of-care device, which identifies the sickle-cell Disease SCD. It is self contained, portable and battery operated making it suitable for mass screening of rural population without affecting their routine work.
Benefits
The epidemiological report states that millions of people are affected by SCD worldwide mainly in sub-Saharan Africa, central India, and eastern Brazil. It is of growing importance in the global health context specially affecting the rural and tribal community in a developing country like India.
Chrogene Aarogyam Biotech Private Limited, Hyderabad.
Accessibility Controls